Álvarez Rodríguez L, López-Hoyos M, Mata C, Fontalba A, Calvo Alen J, Marín MJ, Fernández-Luna JL, Aguero Balbín J, Aranzamendi Zaldunbide M, Blanco R, Martínez-Taboada VM. Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis. Ann. Rheum. Dis. 2011; 70:1677-1683. F.I.: 9,082

Alvarez-Rodriguez L, López-Hoyos M, Beares I, Mata C, Garcia-Unzueta M, Calvo-Alen J, Blanco R, Aurrecoechea E, Tripathi G, Martinez-Taboada VM. Toll-like receptor 4 gene polymorphisms in polymyalgia rheumatica and elderly-onset rheumatoid arthritis. Clin. Exp. Rheumatol. 2011; 29:795-800. F.I.: 2,358

Alvarez-Rodriguez L, Lopez-Hoyos M, Beares I, Muñoz Cacho P, Mata C, Calvo-Alen J, Corrales A, Tripathi G, Blanco R, Garcia-Unzueta M, Villa I, Martinez-Taboada VM. Lack of association between Toll-like receptor 4 gene polymorphisms and giant cell arteritis. RHEUMATOLOGY 2011; 50:1562-1568. F.I.: 4,171

Alvarez-Rodriguez L, Muñoz Cacho P, Lopez-Hoyos M, Beares I, Mata C, Calvo-Alen J, Villa I, Martinez-Taboada VM. Toll-like receptor 4 gene polymorphism and giant cell arteritis susceptibility: a cumulative meta-analysis. Autoimmun. Rev. 2011; 10:790-792. F.I.: 6,556

Arias Guillén M, Palomar R, Arias M. Avances en el diagnóstico de la infección tuberculosa latente en pacientes en tratamiento renal sustitutivo. Nefrologia 2011; 31:137-141. F.I.: 0,738

Arias M, Serón D, Moreso F, Bestard O, Praga M. Chronic renal allograft damage: existing challenges. Transplantation 2011; 91:0-25. F.I.: 3,676

Arnau A, Ruiz JC, Rodrigo E, Quintanar JA, Arias M. Is proteinuria reversible, after withdrawal of mammalian target of rapamycin inhibitors?. Transplant. Proc. 2011; 43:2194-2195. F.I.: 0,993

Arnson Y, Amital H, Agmon-Levin N, Alon D, Sánchez-Castañón M, López-Hoyos M, Matucci-Cerinic M, Szücs G, Shapira Y, Szekanecz Z, Shoenfeld Y. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun. Rev. 2011; 10:490-494. F.I.: 6,556

de Francisco AL. Sustainability and equity of renal replacement therapy in Spain. Nefrologia 2011; 31:241-246. F.I.: 0,738

de Francisco AL, Kim J, Anker SD, Belozeroff V, Canaud B, Chazot C, Drüeke TB, Eckardt KU, Floege J, Kronenberg F, Macdougall IC, Marcelli D, Molemans B, Passlick-Deetjen J, Schernthaner G, Stenvinkel P, Wheeler DC, Fouqueray B, Aljama P. An Epidemiological Study of Hemodialysis Patients Based on the European Fresenius Medical Care Hemodialysis Network: Results of the ARO Study. Nephron. Clin. Pract. 2011; 118:0-0. F.I.: 1,843

de Francisco AL, Piñera C. Nephrology around Europe: organization models and management strategies: Spain. J. Nephrol. 2011; 24:438-445. F.I.: 1,623

de Francisco AL, Piñera C. Anemia trials in CKD and clinical practice: refining the approach to erythropoiesis-stimulating agents. Contrib.Nephrol. 2011; 171:248-254. F.I.: 1,274

Floege J, Kim J, Ireland E, Chazot C, Drueke T, de Francisco A, Kronenberg F, Marcelli D, Passlick-Deetjen J, Schernthaner G, Fouqueray B, Wheeler DC. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol. Dial. Transplant. 2011; 26:1948-1955. F.I.: 3,564

Gayoso-Diz P, Otero-Gonzalez A, Rodriguez-Alvarez MX, Gude F, Cadarso-Suarez C, García F, de Francisco A. Insulin resistance index (HOMA-IR) levels in a general adult population: curves percentile by gender and age. The EPIRCE study. Diabetes Res. Clin. Pract. 2011; 94:146-155. F.I.: 2,134

González-Castro A, Suárez-Lopez V, Gómez-Marcos V, González-Fernandez C, Iglesias-Posadilla D, Burón-Mediavilla J, Rodríguez-Borregan JC, Miñambres E, Llorca J. Valor de la fracción de espacio muerto (Vd/Vt) como predictor de éxito en la extubación. Med. Intensiv. 2011; 35:529-538. F.I.: 1,496

Grau T, Bonet A, Miñambres E, Piñeiro L, Irles JA, Robles A, Acosta J, Herrero I, Palacios V, Lopez J, Blesa A, Martínez P. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit. Care Med. 2011; 39:1263-1268. F.I.: 6,254

Guirado L, Cantarell C, Franco A, Huertas EG, Fructuoso AS, Fernández A, Gentil MA, Rodríguez A, Paul J, Torregrossa JV, Rodríguez A, Alonso A, Hernández D, Burgos D, Jiménez C, Jimeno L, Lauzurica R, Mazuecos A, Osuna A, Plumed JS, Ruiz JC, Zárraga S. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients. Am. J. Transplant. 2011; 11:1965-1971. F.I.: 6,051

Heidt S, San Segundo D, Shankar S, Mittal S, Muthusamy AS, Friend PJ, Fuggle SV, Wood KJ. Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation. Transplantation 2011; 92:1-9. F.I.: 3,676

Heidt S, Shankar S, Muthusamy AS, San Segundo D, Wood KJ. Pretransplant serum CXCL9 and CXCL10 levels fail to predict acute rejection in kidney transplant recipients receiving induction therapy. Transplantation 2011; 91:0-0. F.I.: 3,676

Jiménez-Bonilla JF, Quirce R, Rodrigo E, Banzo I, Martínez-Rodríguez I, Carril JM. Hepatorenal polycystic disease and fever: diagnostic contribution of gallium citrate Ga 67 scan and fluorine F 18 FDG-PET/CT. Eur. Urol. 2011; 59:297-299. F.I.: 8,843

Klareskog L, Gaubitz M, Rodríguez-Valverde V, Malaise M, Dougados M, Wajdula J. Assessment of long-term safety and efficacy of etanercept in a 5-year extension study in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 2011; 29:238-247. F.I.: 2,358

Li PK, Cheung WL, Lui SL, Blagg C, Cass A, Hooi LS, Lee HY, Locatelli F, Wang T, Yang CW, Canaud B, Cheng YL, Choong HL, de Francisco AL, Gura V, Kaizu K, Kerr PG, Kuok UI, Leung CB, Lo WK, Misra M, Szeto CC, Tong KL, Tungsanga K, Walker R, Wong AK, Yu AW. Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis. Nephrology 2011; 16:53-56. F.I.: 1,172

Mann JF, de Francisco A, Nassar G, Canaud B. Fewer dose changes with once-monthly C.E.R.A. in patients with chronic kidney disease. Clin. Nephrol. 2011; 76:9-15. F.I.: 1,058

Miñambres E, Zurbano F, Naranjo S, González-Castro A, Mons R, González-Fernández C, Fernández-Rozas S, Ballesteros MA. Trasplante pulmonar con donantes de edad marginal (= 55 años). Med. Intensiv. 2011; 35:403-409. F.I.: 1,496

Naiyanetr P, Butler JD, Meng L, Pfeiff J, Kenny TP, Guggenheim KG, Reiger R, Lam K, Kurth MJ, Ansari AA, Coppel RL, López-Hoyos M, Gershwin ME, Leung PS. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J. Autoimmun. 2011; 37:209-216. F.I.: 8,136

Palomar R, Arias Guillén M, Robledo C, Agüero R, Agüero J, Rodríguez C, Molinos L, Rodrigo E, Ortega F, Arias M. Detección de la infección tuberculosa latente en pacientes en diálisis peritoneal: Nuevos métodos. Nefrologia 2011; 31:169-173. F.I.: 0,738

Ramos R, Alcázar R, Otero A, de Francisco AL, del Pino MD. Economic impact of vitamin D treatment on chronic kidney disease patients. Nefrologia 2011; 31:528-536. F.I.: 0,738

Rodrigo E, Santos L, Piñera C, Quintanar JA, Ruiz JC, Fernández-Fresnedo G, Palomar R, Gómez-Alamillo C, Arias M. Early prediction of new-onset diabetes mellitus by fifth-day fasting plasma glucose, pulse pressure, and proteinuria. Transplant. Proc. 2011; 43:2208-2210. F.I.: 0,993

Sánchez-Tomero JA, Rodríguez-Jornet A, Balda S, Cigarrán S, Herrero JC, Maduell F, Martín J, Palomar R. Exploring the opinion of CKD patients on dialysis regarding end-of-life and Advance Care Planning. Nefrologia 2011; 31:449-456. F.I.: 0,738

Sellarés J, Moreso F, Ruiz JC, Seron D. Mean glomerular volume after renal transplantation in patients receiving sirolimus and cyclosporine a compared with elimination of cyclosporine a at 3 months. Transplantation 2011; 91:0-0. F.I.: 3,676

Tavira B, Coto E, Díaz-Corte C, Ortega F, Arias M, Torres A, Díaz JM, Selgas R, López-Larrea C, Campistol JM, Ruiz-Ortega M, Alvarez V. KCNQ1 gene variants and risk of new-onset diabetes in tacrolimus-treated renal-transplanted patients. Clin. Transplant. 2011; 25:0-0. F.I.: 1,751

Val-Bernal JF, Garijo MF, Val D, Rodrigo E, Arias M. C4d immunohistochemical staining is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in membranous glomerulonephritis. Histol. Histopath. 2011; 26:1391-1397. F.I.: 2,502

Val-Bernal JF, Rodrigo E, Ruiz-Criado J, Garijo MF, Martín-Gago J, Sanz P. Incidental detection of oncocytosis in a renal biopsy specimen for idiopathic nephrotic syndrome. Pathol. Res. Pract. 2011; 207:733-736. F.I.: 1,258